Andrii Iakovliev
Edinburgh, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Genome-Wide Aggregated Trans-Effects Analysis Implicates Deficient Type III Interferon Signaling as a Key Cause of Inflammatory Bowel Disease.
Journal: Inflammatory bowel diseases
Published: April 25, 2025
Genome-Wide Aggregated Trans Effects Analysis for Circulating Proteins Indicates a Key Role of Immune Checkpoints in Type 1 Diabetes.
Journal: Diabetes
Published: January 21, 2025
Discovery of core genes for systemic lupus erythematosus via genome-wide aggregated trans-effects analysis.
Journal: Genes and immunity
Published: December 14, 2024
Genome-Wide Aggregated Trans Effects Analysis Identifies Genes Encoding Immune Checkpoints as Core Genes for Rheumatoid Arthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: September 17, 2024
Genetics of C-Peptide and Age at Diagnosis in Type 1 Diabetes.
Journal: Diabetes
Published: April 19, 2024
Expression quantitative trait loci analysis in rheumatoid arthritis identifies tissue specific variants associated with severity and outcome.
Journal: Annals of the rheumatic diseases
Published: June 05, 2023
Molecular subtypes explain lupus epigenomic heterogeneity unveiling new regulatory genetic risk variants.
Journal: NPJ genomic medicine
Published: April 03, 2023
Genome-wide aggregated trans-effects on risk of type 1 diabetes: A test of the "omnigenic" sparse effector hypothesis of complex trait genetics.
Journal: American journal of human genetics
Published: December 22, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026